Samil Pharmaceutical Co.,Ltd (KRX: 000520)

Market Cap	272.95B
Revenue (ttm)	210.73B
Net Income (ttm)	-1.16B
Shares Out	21.16M
EPS (ttm)	-74.70
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	474,070
Open	13,100
Previous Close	13,340
Day's Range	12,640 - 13,690
52-Week Range	6,030 - 19,500
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Samil Pharmaceutical Co.,Ltd

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Se...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 586
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000520